Embolization of high-flow craniofacial vascular malformations with onyx.
OBJECTIVE
Various techniques and materials have been used for the endovascular treatment of craniofacial high-flow arteriovenous vascular malformations, because their rarity precludes standardization of their treatment. The aim of this retrospective review is to assess Onyx as the primary embolic agent in the treatment of these vascular malformations.


METHODS
Six patients with arteriovenous fistulas and 3 with arteriovenous malformations (AVMs) of the head and neck region were treated with intra-arterial (IA)/direct percutaneous injections of Onyx. Adjunctive maneuvers used during embolization included external compression of the arterial feeders or venous outflow (6 patients), balloon assist (4 patients), and direct embolization of the draining vein remote to the fistula site (1 patient). n-butyl-2-cyanoacrylate (n-BCA) was used in addition to Onyx for rapid induction of thrombosis in a large venous pouch (1 patient) and for cost containment purposes (1 patient). Four patients were treated surgically after the embolization.


RESULTS
There were no neurologic complications secondary to the embolization procedure. The arteriovenous shunt was eliminated in all of the fistulous lesions and 2 of the 3 AVMs. The embolization was incomplete in 1 patient with a large AVM who declined further endovascular or surgical procedures. Untoward events included 2 instances of catheter entrapment (of 9 IA injections), blackish skin discoloration necessitating surgical revision in 1 patient, and difficulty of balloon deflation/wire withdrawal during a balloon-assisted embolization.


CONCLUSIONS
Onyx appears to be a safe and effective liquid embolic agent for use in the treatment of craniofacial high-flow vascular malformations with distinct advantages and disadvantages compared with n-BCA.
Arat
A
A
Department of Radiology, Baylor College of Medicine, Houston, TX 77030, USA, and Hacettepe University Hospitals, Ankara, Turkey. anilarat@netscape.net
Cil
B E
BE
Vargel
I
I
Turkbey
B
B
Canyigit
M
M
Peynircioglu
B
B
Arat
Y O
YO
D000328:Adult; D002648:Child; D019465:Craniofacial Abnormalities / Q000628:therapy*; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000628:therapy*; D008297:Male; D011145:Polyvinyls / Q000627:therapeutic use*; D016896:Treatment Outcome
C450660:Onyx copolymer; D011145:Polyvinyls; D004121:Dimethyl Sulfoxide
Radiology. 2001 Nov;221(2):309-17
11687669
AJNR Am J Neuroradiol. 2006 Jun-Jul;27(6):1346-9
16775294
Laryngoscope. 2003 Nov;113(11):1885-92
14603041
AJNR Am J Neuroradiol. 1980 Jan-Feb;1(1):71-5
6779593
Neurosurgery. 2006 Jul;59(1 Suppl 1):ONSE169-70; discussion ONSE169-70
16888563
Clin Neuropathol. 2002 Jan-Feb;21(1):13-7
11846039
Interv Neuroradiol. 2005 Oct 5;11(Suppl 1):159-64
20584470
Neurosurgery. 2001 May;48(5):984-95; discussion 995-7
11334300
Radiology. 1999 Jun;211(3):661-6
10352589
J Laryngol Otol. 2005 Apr;119(4):322-4
15949092
AJNR Am J Neuroradiol. 2001 Aug;22(7):1419-23
11498440
Neuroradiology. 2004 Dec;46(12):1012-5
15536559
J Vasc Interv Radiol. 2004 Sep;15(9):939-46
15361561
AJNR Am J Neuroradiol. 2006 Aug;27(7):1535-40
16908575
Plast Reconstr Surg. 1999 Jul;104(1):1-11; discussion 12-5
10597669
Plast Reconstr Surg. 1998 Sep;102(3):643-54
9727427